Pharmapack Europe: 2017 marks 20 years of the pharma packaging and drug delivery event!


Meet with leading suppliers and discover the latest innovations in the industry

Pharmapack Europe (#PharmapackEU), organised by UBM EMEA, is a two-day exhibition and conference dedicated to pharmaceutical packaging, drug delivery and affiliated industries. Next year’s event is on 1 & 2 February 2017 at Paris Expo Porte de Versailles (Hall 4), Paris.

2017 marks the event’s 20th successful year, and over its lifetime it has grown in size, profile and popularity from a bi-annual event to a major annual show that attracts 5,100+ visitors and over 380 exhibitors from more than 70 countries around the world.

Attendees and delegates range from CEOs and CMCs to pharmacists and business execs, and work in every area from R&D and drug development to purchasing, engineering, marketing, logistics and business development.

Innovation is at the very heart of Pharmapack. An Innovation Gallery showcases selected industry innovations from exhibitors, while Innovation Tours guided by industry experts take visitors on a tour to innovating exhibitors’ stands.

The newest addition for 2017, the Pharmapack Start-up Hub, is designed to let innovative young pharma firms benefit from valuable networking and learning opportunities at a price that suits their budget. This dedicated area on the show floor gives them a unique platform to showcase their ideas, meet potential customers, partners and investors and forge new relationships that will help them develop for years to come.

The Pharmapack Awards recognize new products that are set to shape the future of the industry, in two categories. The Exhibitor Innovations category is dedicated to Pharmapack exhibitors who have developed a new product. For those who are not exhibiting, there is the Health Product category. This latter category distinguishes the packaging of new health products introduced to the market, or the improvement of the packaging of an existing health product (for human or veterinary use).

Both Awards recognize products that have significantly contributed to the proper use of medication, increased patient/user safety and compliance or represent a significant step towards sustainable packaging.

Pharmapack is a unique opportunity to sharpen up technical and industry knowledge. The extensive content programme comprises two days of conferences, a one-day Serialisation, Track and Trace Symposium, a day of Workshops and a Learning Lab that hosts short, sharp presentations on key topics from exhibitors throughout the 2 show days.

Dedicated networking areas and a special drinks reception mean there’s never a shortage of new faces to meet. It’s a unique opportunity for companies to boost their networks and kick-start their growth.

For more information visit here and get registered for Pharmapack Europe 2017!

pharmapack_2 pharmapack_3


European Pharmaceutical Market Access, Pricing & Reimbursement Conference


Conference: 10th October to 11th October 2016
Workshops: 12th October 2016
Holiday Inn Kensington Forum, London, United Kingdom

SMi Group’s 22nd annual European Pharmaceutical Market Access, Pricing and Reimbursement conference returns to London from 10-11 October 2016. The conference is one of the most established in the world, focusing on the changes in pricing and reimbursement and market access.

Key topics include:
• Updates on AMNOG and its implication on pricing and reimbursement
• How biosimilars are affecting your pricing strategy
• Capture on emerging markets’ regulatory framework to adapt your market access and P&R models
• Orphan drugs using recent examples to highlight the impact on pricing
• Cancer drug funding and budget cuts in the UK
• Innovative solutions beyond the pill
• Japanese and Turkish regional updates


• Simone Breitkopf, Head HEOR, Governmental and Public Affairs, Alcon
• Ulf Staginnus, Head Market Access Oncology, Region Europe, Baxalta
• Gordon Spencer, Regional Market Access Lead – EU & Canada, Shire International GmbH
• Alexander Natz, Secretary General, EUCOPE
• David Watson, Director of Pricing and PPRS, Association of the British Pharmaceutical Industry
• Panos Kefalas, Head of Health Economics and Market Access, Cell & Gene Therapy Catapult
• Ken Walsh, Senior Principal, Global Payer Strategy Consulting, Evidera

The conference will feature two exclusive post-conference workshops:

A: HTA and reimbursement decisions for innovative medicines
Workshop Leader: Patrick Mollon, Former Director Global Health Economics & Outcomes Research, Novartis; HEOR Director, PMHE2020

B: Managing the global to local challenge
Workshop Leader: Janice Haigh, Practice Leader, Quintiles

For more information please visit:

To register: contact Fateja Begum on +44 (0)20 7827 6184 or email: